Today: 23 June 2026
Browse Category

NASDAQ:CPRX 15 December 2025 - 30 December 2025

Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals shares fell 3% to $23.33 in thin afternoon trading Tuesday, extending a two-day slide and leaving the stock about 12% below its June high. Biotech ETFs underperformed the broader market, with the iShares Nasdaq Biotechnology ETF down 1.2%. Investors are awaiting the Federal Reserve’s meeting minutes and Catalyst’s next update in January.
30 December 2025
··
Catalyst Pharmaceuticals CPRX Stock News, Forecasts and Analyst Outlook for December 15, 2025

Catalyst Pharmaceuticals CPRX Stock News, Forecasts and Analyst Outlook for December 15, 2025

Catalyst Pharmaceuticals confirmed CEO Rich Daly will present at the J.P. Morgan Healthcare Conference on January 12, 2026. CPRX traded near $23.95 Monday, below the $26.58 technical level watched by traders. Shares saw volume around 822,000 and a Relative Strength Rating increase from 61 to 73. Analysts cited ongoing debate over the stock’s next move after a strong year.
15 December 2025
·

Stock Market Today

  • Investors Misinterpret Fed Support, Greenspan Put a Myth
    June 23, 2026, 9:18 AM EDT. Wall Street investors expect the Federal Reserve to act as a safety net during market downturns, often referred to as a 'put' option. However, the belief in a 'Warsh put'-named after former Fed official Richard Warsh-and the 'Greenspan put' is misplaced. The Federal Reserve's response during the dot-com crash reflected adherence to policy rules rather than efforts to protect stock portfolios directly. This misunderstanding could lead investors to overestimate the Fed's market interventions, impacting investment strategies and risk assessments.

Latest articles

Nasdaq Futures Drop Ahead of Open as Debt Concerns Hit AI Stocks

Nasdaq 100 Slides, Tech Stocks Wipe Out $1 Trillion

23 June 2026
Nasdaq 100 futures plunged nearly 3% premarket as selling in AI-linked tech stocks intensified, putting over $1 trillion in market value at risk Tuesday; SpaceX dropped below a $2 trillion valuation and lost $600 billion in three sessions, while South Korea’s KOSPI tumbled 9.99% after Samsung and SK Hynix fell over 12% each, as investors question AI returns and brace for higher U.S. rates.
Keel (NYSE:KEEL) Faces Major AI Test After Rally

Keel (NYSE:KEEL) Faces Major AI Test After Rally

23 June 2026
Keel Infrastructure Corp shares slipped pre-market after hitting a 52-week high Monday, as investors weigh the upcoming June 26 addition to the Russell 3000 Index and the recent $458 million convertible note offering with a $7.41 conversion price, while the company remains in transition with declining revenue, a $127.6 million quarterly loss, and key data-center leases still unsigned.
Nokia Oyj (HEL:NOKIA, NYSE:NOK) slips heading into Q2; AI-optical momentum pressured

Nokia (HEL:NOKIA) gives back AI-fueled gains after Google Cloud news

23 June 2026
Nokia shares dropped 2.5% in Helsinki after a U.S. rally sparked by a Google Cloud AI partnership, as investors weighed the new Gemini-based tools against a weaker Finnish market and sector-wide AI pullback; Nokia’s ADRs had surged 6.97% on Monday after announcing six specialized AI agents for telecom networks, with the first agent pack set for Google Cloud Marketplace in September.
Go toTop